Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response

Targeted delivery of a nanovaccine loaded with a tumor antigen and adjuvant to the lymph nodes (LNs) is an attractive approach for improving cancer immunotherapy outcomes. However, the application of this technique is restricted by the paucity of suitable tumor-associated antigens (TAAs) and the sop...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xiang, Dai, Yanfeng, Zhao, Yifan, Qi, Shuhong, Liu, Lei, Lu, Lisen, Luo, Qingming, Zhang, Zhihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048802/
https://www.ncbi.nlm.nih.gov/pubmed/32111828
http://dx.doi.org/10.1038/s41467-020-14906-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048802/
https://www.ncbi.nlm.nih.gov/pubmed/32111828
http://dx.doi.org/10.1038/s41467-020-14906-9

Ejemplares similares